EDGEMOND JAMES 4
4 · UNITED THERAPEUTICS Corp · Filed Mar 27, 2026
Research Summary
AI-generated summary of this filing
United Therapeutics (UTHR) CFO James Edgemond Sells Shares After Exercise
What Happened
James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics (UTHR), exercised stock options to acquire 10,000 shares at a strike price of $135.42 (cost $1,354,200) on March 26, 2026, and subsequently sold those 10,000 shares in multiple open-market trades the same day. The sales generated approximately $5.36 million in gross proceeds. The pattern—exercise followed by immediate sales—is consistent with a cashless exercise where acquired shares are sold rather than retained.
Key Details
- Transaction date: March 26, 2026 (Form filed March 27, 2026). Filing appears timely (next business day).
- Exercise: 10,000 shares acquired at $135.42/share (total cost $1,354,200). (Code M = exercise/conversion of derivative)
- Open-market sales: 10,000 shares sold across multiple trades; gross proceeds ≈ $5,359,004. Weighted average sale prices for the tranches ranged roughly from $531.42 to $540.36 (see footnotes for tranche ranges).
- Reported derivative disposition: a related M-code line shows 10,000 shares with $0 reported — a Form 4 reporting convention tied to the exercise/sale sequence.
- Footnote: Transactions were executed under a Rule 10b5-1 trading plan entered October 31, 2025 (per Footnote F1). Several footnotes (F2–F10) note each sale tranche was done in multiple trades with reported weighted-average prices; full trade-level details are available on request.
- Shares owned after transaction: Not specified in the summary info provided in your request.
Context
- This was an option exercise followed by immediate open-market sales (a common way for insiders to realize option value and cover the exercise cost and taxes). Such sales are routine and, because they were executed under a 10b5-1 plan, were prearranged trades that limit timing concerns.
- Transaction code notes: M = exercise/conversion of derivative; S = sale. Purchases/sales by executives are factual signals of realized gains but should not be taken alone as endorsement or negative view of the company.
Insider Transaction Report
Form 4
EDGEMOND JAMES
CFO AND TREASURER
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-26$135.42/sh+10,000$1,354,200→ 28,876 total - Sale
Common Stock
[F1][F2]2026-03-26$532.02/sh−991$527,236→ 27,885 total - Sale
Common Stock
[F1][F3]2026-03-26$532.93/sh−510$271,794→ 27,375 total - Sale
Common Stock
[F1][F4]2026-03-26$533.91/sh−609$325,153→ 26,766 total - Sale
Common Stock
[F1][F5]2026-03-26$534.98/sh−1,847$988,101→ 24,919 total - Sale
Common Stock
[F1][F6]2026-03-26$535.94/sh−2,003$1,073,491→ 22,916 total - Sale
Common Stock
[F1][F7]2026-03-26$536.90/sh−1,577$846,689→ 21,339 total - Sale
Common Stock
[F1][F8]2026-03-26$537.90/sh−1,149$618,046→ 20,190 total - Sale
Common Stock
[F1][F9]2026-03-26$538.91/sh−994$535,680→ 19,196 total - Sale
Common Stock
[F1][F10]2026-03-26$540.04/sh−320$172,814→ 18,876 total - Exercise/Conversion
Stock Option
[F1]2026-03-26−10,000→ 142,500 totalExercise: $135.42From: 2023-03-15Exp: 2027-03-15→ Common Stock (10,000 underlying)
Footnotes (10)
- [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- [F10]This transaction was executed in multiple trades at prices ranging from $539.66 to $540.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $531.42 to $532.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $532.42 to $533.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $533.45 to $534.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $534.48 to $535.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $535.48 to $536.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $536.48 to $537.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F8]This transaction was executed in multiple trades at prices ranging from $537.50 to $538.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F9]This transaction was executed in multiple trades at prices ranging from $538.61 to $539.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ John S. Hess, Jr. under Power of Attorney|2026-03-27